Oct
04

Testosterone for Women: Current AACE Guidelines vs What the Literature Says

Testosterone for Women: Current AACE Guidelines vs What the Literature Says by Neal Rouzier, MD In Testosterone for Women Part 1: The Evidence and Benefits No One Talks About, I presented the studies/papers demonstrating that symptom improvement is only achieved with supraphysiologic levels of testosterone. Rebecca Glasser, a well-respected and published breast cancer surgeon, proves
DETAIL
Sep
08

Testosterone for Men: Reduction in CVD, Prevention and Reversal of Diabetes, with the Resultant Reduction in CVD Mortality

Reduction in CVD, Prevention and Reversal of Diabetes, with the Resultant Reduction in CVD Mortality by Neal Rouzier, MD Testosterone for Men: Part 7 is a continuation of the articles discussed in Testosterone for Men: Part 6 that further review all the literature demonstrating testosterone’s benefit for weight loss, reduction of visceral fat, improvement in
By Neal Rouzier | Blog . Testosterone
DETAIL
Sep
07

Testosterone for Men: Facts, Figures and Literature that you Should Know Before Prescribing Testosterone

Testosterone for Men: Facts, Figures and Literature that you Should Know Before Prescribing Testosterone by Neal Rouzier, MD The more articles that demonstrate the benefits of testosterone, the more there is pushback against the use of testosterone. Every day I encounter a PMD or specialist that criticizes my use of testosterone, despite the fact that
By Neal Rouzier | Blog . Case Studies . Testosterone
DETAIL
Sep
06

Testosterone for Women: The Studies that Prove Testosterone is Absolutely Necessary for CVD Protection

Testosterone for Women: The Studies that Prove Testosterone is Absolutely Necessary for CVD Protection  by Neal Rouzier, MD For the first several courses on Testosterone for Women, I addressed the diagnosis of Andropause (Hypogonadism), the problems with making a diagnosis, the controversies, and faults of using labs to make the diagnosis. As well as the
By Neal Rouzier | Blog . Testosterone
DETAIL
Sep
02

Treating T3 Deficiency (Part 6) Why T4 Thyroxine Therapy does not Improve Symptoms and Why TSH Suppression does NOT Result in Harm

Why T4 Thyroxine Therapy does not Improve Symptoms and Why TSH Suppression does NOT Result in Harm by Neal Rouzier, MD On Day 1 of the Part I BHRT Workshop Series, I introduced the concept that “Association Does Not Prove Causation (ADNPC).” Every course subsequent to Part I, I have to reintroduce the concept as
DETAIL
Jul
12

Testosterone for Women: The Levels Necessary to Achieve Symptom Improvement

In the first course, Testosterone for Women (Part I), I reviewed the current controversy in prescribing testosterone to women. In a separate consensus paper that is different from the one discussed in the first course, the authors recommend testosterone replacement based on symptoms and signs and not on serum levels. In fact, in this second consensus paper from “experts that have experience in the field of testosterone administration,” the authors stressed the importance of replacing testosterone to improve symptoms and not by being guided by numbers or levels. These authors specifically emphasized that testosterone should be supplemented based on symptoms and not just on serum levels alone, as testosterone levels do not correlate with symptoms as per much of the medical literature. The authors also suggested that testosterone should be dosed and adjusted based on symptom improvement, and not by testosterone levels. The authors reiterated that no number (or testosterone level) denotes a deficiency as symptoms denote a deficiency. Furthermore, improvement in symptoms do not correlate with numbers either as all women will respond differently and not based on any number. So, in contrast to men where the guidelines state that we must follow levels and numbers, these guidelines for women recommend that we do not test baseline levels nor treatment levels, rather symptoms should guide treatment initiation.

DETAIL
Jun
03

Testosterone for Women: The Evidence and Benefits No One Talks About

A 45 year old female presents to you complaining of fatigue, loss of energy, weight gain, muscle pain, and weakness in exercising. 

She read about the benefit of hormones in treating her condition, but her PMD is against the use of hormones. Although she is open to taking hormones, her PMD scared her into thinking that testosterone is somehow harmful. You assure her that testosterone is not harmful and that many of her symptoms will improve on testosterone supplementation. 

By Neal Rouzier | Blog . Testosterone
DETAIL
Apr
18

6 Important Qualities to Look For in Hormone Replacement Training

We have explored the pandemic of chronic illness that patients are experiencing. We have also explored how hormone replacement therapy can safely and effectively prevent or even treat many chronic illnesses by delving into the robust medical literature supporting hormone replacement. After learning how Bioidentical Hormone Replacement Therapy (BHRT) can help patients fight chronic disease, providers may ultimately desire to add this form of medicine to their practice, so how do they go about doing that? The answer: training, of course.

DETAIL
Apr
14

What is BHRT and 5 ways it Could Benefit Your Patients

Previously, we discussed how patients are taking more medications and experiencing an endless conundrum of health issues. The systemic failure to address the root causes of disease is a huge part of the problem. Along with the proven benefits of a healthy diet, exercise, and stress management, we can greatly improve health outcomes by utilizing another evidence-based strategy: bioidentical hormone replacement therapy, or BHRT. 

DETAIL
Feb
08

High Dose Replacement and Thyroid Optimization

The previous course on thyroid optimization was intended to contrast and explain how and why the endocrine societies and the ATA frighten us into not using thyroid hormone. I introduced the concepts that the endocrinologists use when treating hypothyroid patients as well as their reluctance to prescribe thyroid hormone to SC hypothyroid patients. Despite the plethora of data and studies proving that patients DON’T improve on T4-alone therapy, the ATA and AACE reject all the studies demonstrating that patients DO benefit when T3 is added to T4, but also when DTE is used preferentially in place of T4-alone or T4 and low dose T3. When used correctly, most recent literature overwhelming proves that patients prefer DTE over any other thyroid preparation.

DETAIL